LSA
BIIB icon

Lansing Street Advisors’s Biogen BIIB Stock Holding History

Lansing Street Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$4.84K Hold
17
– – ﹤0.01% 231
2023
Q1 		$4.73K Hold
17
– – ﹤0.01% 245
2022
Q4 		$4.71K Hold
17
– – ﹤0.01% 255
2022
Q3 		$5K Hold
17
– – ﹤0.01% 212
2022
Q2 		$3K Hold
17
– – ﹤0.01% 212
2022
Q1 		$4K Buy
+17
New +$3.7K ﹤0.01% 226

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Lansing Street Advisors's BIIB Position: Q2 2023 in Review

Lansing Street Advisors held its Biogen (BIIB) position steady in Q2 2023 at 17 shares worth $4.84K. The position accounts for ﹤0.01% of the portfolio, ranked #231.

Lansing Street Advisors first reported a position in BIIB in Q1 2022 and has held it in 6 quarters since. The position peaked at $5K in Q3 2022. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Lansing Street Advisors held 17 shares of Biogen worth $4.84K as of Q2 2023.
  • Lansing Street Advisors left its Biogen share count unchanged in Q2 2023.
  • Biogen made up ﹤0.01% of Lansing Street Advisors's portfolio in Q2 2023, its #231 holding.
  • Lansing Street Advisors first reported a position in Biogen in Q1 2022 and has held it in 6 quarters since.
  • Lansing Street Advisors's Biogen position peaked at $5K in Q3 2022.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Lansing Street Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.